Latest Hematology / Oncology Articles

• Trends in Industry Payments to US Oncologists Since the Open Payments Program, 2014 to 2019 March 1, 2021
  This cohort study of medical oncologists in the US examines trends in physician-level payments in 2014 to 2019 to determine if implementation of the Open Payments program is associated with changes in the frequency and value of industry-oncologist payments.
• Effect of Adjuvant Paclitaxel and Carboplatin on Survival in Triple-Negative Breast Cancer—Reply March 1, 2021
  In Reply We would like to thank Arora et al for their interest in our PATTERN (adjuvant Platinum and Taxane in Triple-Negative Breast Cancer) randomized clinical trial and their thoughtful comments on the article. First, we agree with their statement that “the PATTERN trial adds to the evidence that an anthracycline-free regimen may be considered […]
• When the Signal From Phase 2 Research Should Be a Warning Sign March 1, 2021
  The article by Akamatsu and colleagues in this issue of JAMA Oncology describes a phase 2 randomized clinical trial that tests the value of adding the vascular endothelial growth factor inhibitor bevacizumab to osimertinib in 81 Japanese patients with EGFR mutation–positive advanced non–small cell lung cancer (NSCLC) and T790M mutation–positive acquired resistance on a prior […]